MedTrace Logo

Tolerance and Acceptability Evaluation of STOCKHOLM

NCT03844373 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-01-06

No results posted yet for this study

Summary

Tolerance and Acceptability of new oral nutritional supplement - STOCKHOLM.

Conditions

  • Malnutrition

Interventions

DIETARY_SUPPLEMENT

STOCKHOLM

STOCKHOLM is a Food for Special Medical Purposes (FSMP) and must, therefore, be used under medical supervision.

Sponsors & Collaborators

  • Aymes International Limited

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-02
Primary Completion
2020-12-01
Completion
2020-12-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03844373 on ClinicalTrials.gov